Cargando…

Correction to: IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study

Detalles Bibliográficos
Autores principales:	Ciabattoni, Antonella, Gregucci, Fabiana, Fastner, Gerd, Cavuto, Silvio, Spera, Antonio, Drago, Stefano, Ziegler, Ingrid, Mirri, Maria Alessandra, Consorti, Rita, Sedlmayer, Felix
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082906/ https://www.ncbi.nlm.nih.gov/pubmed/33910604 http://dx.doi.org/10.1186/s13058-021-01432-9

Ejemplares similares

IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study
por: Ciabattoni, Antonella, et al.
Publicado: (2021)

Hypofractionated Whole Breast Irradiation and Boost-IOERT in Early Stage Breast Cancer (HIOB): First Clinical Results of a Prospective Multicenter Trial (NCT01343459)
por: Fastner, Gerd, et al.
Publicado: (2022)

Intra-Operative Electron Radiation Therapy (IOERT) Anticipated Boost in Breast Cancer Treatment: An Italian Multicenter Experience
por: Ciabattoni, Antonella, et al.
Publicado: (2022)

Intraoperative radiotherapy (IORT) as boost in breast cancer
por: Sedlmayer, Felix, et al.
Publicado: (2017)

Boost IORT in Breast Cancer: Body of Evidence
por: Sedlmayer, Felix, et al.
Publicado: (2014)

Omission of adjuvant radiotherapy for older adults with early-stage breast cancer particularly in the COVID era: A literature review (on the behalf of Italian Association of Radiotherapy and Clinical Oncology)
por: Palumbo, Isabella, et al.
Publicado: (2021)

Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation
por: Jazmati, Danny, et al.
Publicado: (2022)

Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer
por: Barney, Brandon M, et al.
Publicado: (2013)

Reply to: The challenge of cardiac dose constraint adaptation to hypofractionated breast radiotherapy in clinical practice
por: Piroth, Marc D., et al.
Publicado: (2021)

Long-Term Outcome of Centrally Located Hepatocellular Carcinomas Treated by Radical Resection Combined With Intraoperative Electron Radiotherapy (IOERT)
por: Wu, Yan-Ling, et al.
Publicado: (2022)

Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation
por: Zehentmayr, Franz, et al.
Publicado: (2019)

Intraoperative Electron Radiation Therapy (IOERT) in the management of locally recurrent rectal cancer
por: Roeder, Falk, et al.
Publicado: (2012)

Intraoperative electron radiation therapy (IOERT) in patients with locally recurrent renal cell carcinoma
por: Habl, Gregor, et al.
Publicado: (2013)

Radiation dose escalation with modified fractionation schedules for locally advanced NSCLC: A systematic review
por: Zehentmayr, Franz, et al.
Publicado: (2020)

Boost in radiotherapy: external beam sunset, brachytherapy sunrise
por: Maciejewski, Boguslaw
Publicado: (2009)

Acute Toxicity and Early Oncological Outcomes After Intraoperative Electron Radiotherapy (IOERT) as Boost Followed by Whole Breast Irradiation in 157 Early Stage Breast Cancer Patients—First Clinical Results From a Single Center
por: König, Laila, et al.
Publicado: (2019)

Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer
por: Verrijssen, An-Sofie E., et al.
Publicado: (2022)

Evaluating the induced photon contamination by different breast IOERT shields using Monte Carlo simulation
por: Baghani, Hamid Reza, et al.
Publicado: (2023)

Is there a role for an external beam boost in cervical cancer radiotherapy?(†)
por: Sethi, Rajni A., et al.
Publicado: (2013)

Pulmonary function decreases moderately after accelerated high‐dose irradiation for stage III non‐small cell lung cancer
por: Grambozov, Brane, et al.
Publicado: (2019)

In vivo dosimetry and shielding disk alignment verification by EBT3 GAFCHROMIC film in breast IOERT treatment
por: Severgnini, Mara, et al.
Publicado: (2014)

Chemo-Radio-Immunotherapy for NSCLC III: ESR/ATS Thresholds for DL(CO) Correlate with Radiation Dosimetry and Pneumonitis Rate
por: Stana, Markus, et al.
Publicado: (2023)

Outcome of patients with local recurrent gynecologic malignancies after resection combined with intraoperative electron radiation therapy (IOERT)
por: Arians, Nathalie, et al.
Publicado: (2016)

Carbon Monoxide Diffusing Capacity (DL(CO)) Correlates with CT Morphology after Chemo-Radio-Immunotherapy for Non-Small Cell Lung Cancer Stage III
por: Stana, Markus, et al.
Publicado: (2022)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
por: Mazzola, Rosario, et al.
Publicado: (2019)

State of The Art in Breast Intraoperative Electron Radiation Therapy After Intraoperative Ultrasound Introduction
por: Vidali, Cristiana, et al.
Publicado: (2021)

DEGRO practical guidelines: radiotherapy of breast cancer I: Radiotherapy following breast conserving therapy for invasive breast cancer
por: Sedlmayer, F., et al.
Publicado: (2013)

Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid)
por: Zehentmayr, Franz, et al.
Publicado: (2015)

Poor-Prognosis Patients Affected by Glioblastoma: Retrospective Study of Hypofractionated Radiotherapy with Simultaneous Integrated Boost and Concurrent/Adjuvant Temozolomide
por: Gregucci, Fabiana, et al.
Publicado: (2021)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility Study †
por: Ciabattoni, Antonella, et al.
Publicado: (2022)

Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer
por: Phak, Jeong Hoon, et al.
Publicado: (2016)

Dose distribution changes with shielding disc misalignments and wrong orientations in breast IOERT: a Monte Carlo – GEANT4 and experimental study
por: Russo, Giorgio, et al.
Publicado: (2012)

Impact of reirradiation, chemotherapy, and immunotherapy on survival of patients with recurrent lung cancer: A single‐center retrospective analysis
por: Grambozov, Brane, et al.
Publicado: (2021)

Feasibility and safety of physical exercise in men with prostate cancer receiving androgen deprivation therapy and radiotherapy: a study protocol
por: Bressi, Barbara, et al.
Publicado: (2022)

Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial
por: Roeder, Falk, et al.
Publicado: (2014)

Assessment of response to neoadjuvant radiochemotherapy with F-18 FLT and F-18 FDG PET/CT in patients with rectal cancer
por: Rendl, Gundula, et al.
Publicado: (2014)

The effectiveness and side effects of conformal external beam radiotherapy combined with high-dose-rate brachytherapy boost compared to conformal external beam radiotherapy alone in patients with prostate cancer
por: Smolska-Ciszewska, Beata, et al.
Publicado: (2015)

PROstate Multicentre External beam radioTHErapy Using a Stereotactic boost: the PROMETHEUS study protocol
por: Richardson, Matthew, et al.
Publicado: (2018)

A novel external beam radiotherapy method for cervical cancer patients using virtual straight or bending boost areas; an in-silico feasibility study
por: Cozzi, Luca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gkb9c1fnl9rgn5c2bmaquopnuj